On this page you'll find summarized information about our solutions together with how Vironova is as an employer.
Founded in Stockholm in 2005, Vironova is a world leading partner to the global life science community in the development of novel therapies for tomorrow.
By combining hardware and software solutions for advanced electron microscopy analysis, we support our partners through the whole value chain. From initial sample preparation to imaging and final analytical result, our dedicated team provide insightful and actionable data. We empower clients to make better-informed decisions, to create value and ensure safety for patients worldwide.
The life science market is shifting. Recent successes in genetic medicine have paved the way for a broader wave of therapies and next-generation technologies. As conventional therapies mature, cell and gene therapies are emerging as the future of biopharmaceuticals, representing a pivotal approach to treat previously uncurable diseases and conditions. As a result, the global cell and gene therapy market is expected to grow from 3 to 27 billion dollars by 2025.
Development of novel therapies is a highly regulated, costly and time critical process – setting high standards for secure, reliable and intuitive systems across the entire production line. Vironova is in pole position to capture value and growth opportunities in this ever-evolving landscape. Transmission electron microscopy (TEM) paired with our intelligent software and experience, is the leading method capable of producing a reliable and accurate analysis for the development of novel therapies.
.jpg)
Cost-effective, fast and GMP certified Electron Microscopy services (EMS) enabled by the in-house developed Vironova Analyzing Software (VAS) for semi-automated nanoparticle analysis.
Our electron microscope services team are experts in nanoparticles characterization. We have helped our clients with sample preparation, image acquisition, image analysis and reporting since 2009. With our world's first GMP certified lab, we offer unique solutions to our customers.
The report our clients receive includes representative and high-quality electron microscope images, quantitative analysis and a concluding summary with comments from the expert team. You can request example reports here for different particle analyses.
VAS is a FDA 21 CFR Part 11 compliant software used in TEM based image analysis of nanoparticles. VAS can be operated on MiniTEM and ViroTEM but also on other conventional TEM:s.
Analysis of objects in images can be performed using a combination of automatic analysis tools based on mathematical algorithms, and manually operated tools that aid a domain expert in assessing the images.
Automation is enabled using machine learning, making it possible to set up methods to automatically classify particles. It helps our clients to save up to 12 hours of work on each sample, compared to manual operation.
MiniTEM is a compact and agile transmission electron microscope system designed for automated nanoparticle characterization. High-resolution images reveal particle morphologies that are transformed into accurate metrics.
Our MiniTEM system provides pharmaceutical organizations worldwide with an advanced semi-automated microscope which helps them to save time and hence frees up their time to do other tasks. It also increases reliability with its objective quantitative data and minimized risk of human error. Further, it enables both experts and non-experts to operate the microscope with less focus on the technology and more on the results itself. Using the system, clients will face a simple workflow all the way from sample preparation to particle analysis.
The compact system offers an in-house solution where our clients do not have to wait for service providers. No special infrastructure is needed in order to use the system thanks to its profitable design, weight and technology. It is thereby suitable to be placed in traditional process development or analytical laboratories. MiniTEM is controlled by VIAS.
Be sure to book a free demo to see how our MiniTEM system can help your organization in your imaging and analysis processes. You can also request a quote where one of our senior TEM experts will contact you and provide you with more information about the price.
ViroTEM is an automated, powerful, and versatile TEM system for analysis and characterization of nanoparticles using the Vironova Imaging and Analysis Software (VIAS).
ViroTEM is the system that meets and exceeds requirements in many scientific fields. It is placed in the absolute front line of innovation and provides a solution for modern TEM analyses.
The microscope is equipped with a dual-camera system, enabling efficient and rapid specimen searching in full grid overview as well as image acquisition in high resolution. The system can be used in various application areas, but it is specially powerful in those biotherapeutic applications involving viral structures.
If you want to evaluate how our ViroTEM system can be profitable for your organization you can book a free demo. If you are interested in delivery timeline and investment requirements for the ViroTEM-system you can request a quote here.
VIAS is an intuitive software used by experts and users with with little previous experience to control the TEM, visualize samples, and analyse data.
It is an advanced image analysis tool using pattern recognition and machine learning capabilities to helps users to perform advanced particle characterization, classification and measurements.
VIAS is an imaging and analysis software that controls transmission electron microscopes (TEM) and provides semi-automatic image acquisition as well as subsequent analysis and data presentation. The software can control the MiniTEM and ViroTEM systems.
.png)
Vironova Biosafety is a contract research organization (CRO) specialized in viral clearance studies for biological drugs. Viral clearance testing performed in Vironova Biosafety´s GLP and BSLIII certified laboratories.
We offer viral clearance studies in BSLII and BSLIII certified cell and virus laboratories. We are compliant with good laboratory practice (GLP) principles and have been GLP certified since 2011.
Our services range from early R&D to market release. Literature-based viral risk assessment is also offered by our experts with extensive scientific and regulatory experience.
We are on a mission to build trust in the therapies of tomorrow by making the invisible visible today.
Vironova is the preferred partner for life science companies, setting the golden standard for safe and effective therapy development.
Diversity is highly valued by us, having people from more than 15 different nationalities working in cross-functional and highly domain knowledge specialized teams. We believe it creates an evolving working environment and makes it more fun at work!
We see ourselves as pioneers within our field and are proud and passionate about what we do. We are committed and understand the importance of accuracy to deliver high quality solutions sharpening our clients competitive edge.
If you are looking for a new workplace, you are welcome to our career pages to see what we can offer you.
.jpg)
.jpg)
.jpg)
A great deal of things are going on in the Vironova group and in the industry, which we trendwatch and follow. Take action and follow us on our social media channels and subscribe to our newsletter to stay up to date!
You can also follow us on Mynewsdesk for relevant news updates.
If you have any questions about Vironova, what we do, or how we can help you, please contact us and we will help you to the best of our ability. To find more information about our open positions, please visit our career page.
Join us on social media
© Copyright Vironova 2020, all rights reserved
